Identifying biomarkers to predict disease progression in early stage Parkinson’s disease patients
Objective: To evaluate the sensitivity of instrumented measures of motor dysfunction and candidate serological markers of disease to predict disease progression in de novo Parkinson’s…Minor hallucinations in Parkinson’s disease are associated with increased neurofilament plasma levels and reduced white-matter integrity in the inferior longitudinal fasciculus
Objective: To examine whether patients with Parkinson's disease (PD) and isolated minor hallucinations have increased plasma neurofilament light chain (NfL) levels and/or differences in white…Depression in patients with Parkinson’s disease
Objective: The objective of this study was to correlate PD severity with depression. Background: Depression is the most common psychiatric disorder in patients with PD. In…Severity of Motor Symptoms in Parkinson’s Disease in Kazakhstan (on the example of the city of Almaty)
Objective: Determine the severity of motor symptoms with Parkinson's disease using the MDS-UPDRS scale. Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by…Safety and efficacy of istradefylline, an adenosine A2A receptor antagonist, as a function of baseline dyskinesia (BL-dyskinesia) in Parkinson’s disease (PD): A pooled analysis of 4 studies
Objective: To evaluate the effect of BL-dyskinesia on the efficacy and safety of istradefylline in 4 randomized, placebo-controlled, double-blind, phase 2b/3 trials. Background: Istradefylline, a…Impact of safinamide on non-motor and motor experiences of daily living: Primary results from the prospective, observational ProGo study
Objective: Evaluate the effect of safinamide treatment on non-motor and motor experiences of daily living as assessed using the MDS-UPDRS (Parts I nm-EDLand II m-EDL).…Open data sharing of the Parkinson’s Outcomes Project: A global, longitudinal clinical study of over 13,000 people with Parkinson’s disease
Objective: To describe the newly developed Parkinson’s Outcomes Project data sharing policy to the entire research community with a long-term goal of accelerating novel hypothesis…Effects of Nabilone on non-motor symptoms of Parkinson´s Disease: A randomised placebo-controlled study (The NMS-Nab Study)
Objective: To investigate the effects of the synthetic cannabinoid nabilone for the treatment of non-motor symptoms in Parkinson´s disease (PD) in a controlled fashion. Background:…Resistance Training on Postural Control in Parkinson’s Disease: a Randomized Controlled Trial
Objective: To evaluate changes in postural control following RT using static posturography and clinical functional balance tests in Parkinson’s Disease patients Background: Muscle weakness affects…Clinical research of serum uric acid levels in Parkinson’s disease
Objective: To analyzed the variation of uric acid (UA) traits in different Hoehn-Yahr staging in Parkinson's disease (PD). Background: PD is a common neurodegenerative disease.…
- « Previous Page
- 1
- …
- 125
- 126
- 127
- 128
- 129
- …
- 149
- Next Page »